← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Voss Advisors GP, LLC
10% Owner
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001798309
Purchase history
- Companies traded
- 4
- Purchases · 12M
- 9
- Purchases · 24M
- 9
- Average purchase
- $4.6M
- Median purchase
- $3.2M
- Gross purchase value
- $41.1M
Companies: Flywire Corp | PAR TECHNOLOGY CORP | Rein Therapeutics, Inc. | Xponential Fitness, Inc.
9 SEC accession(s) · 9 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-06-15 | PAR TECHNOLOGY CORP | PAR | 10% Owner | $5.1M | Open filing |
| 2026-05-21 | Xponential Fitness, Inc. | XPOF | 10% Owner | $687.6K | Open filing |
| 2026-05-18 | PAR TECHNOLOGY CORP | PAR | 10% Owner | $9.5M | Open filing |
| 2026-03-05 | PAR TECHNOLOGY CORP | PAR | 10% Owner | $14.7M | Open filing |
| 2026-02-18 | Flywire Corp | FLYW | 10% Owner | $274.8K | Open filing |
| 2026-01-07 | Flywire Corp | FLYW | 10% Owner | $3.2M | Open filing |
| 2026-01-07 | PAR TECHNOLOGY CORP | PAR | 10% Owner | $7.1M | Open filing |
| 2025-11-18 | Rein Therapeutics, Inc. | RNTX | 10% Owner | $127.1K | Open filing |
| 2025-10-28 | Rein Therapeutics, Inc. | RNTX | 10% Owner | $423.5K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 4Small Sample | 44.4% (4/9) | 75.0% (3/4) | +4.6% | +1.7% | -16.6% |
| 20D | 4Small Sample | 44.4% (4/9) | 50.0% (2/4) | -9.1% | -11.3% | -36.2% |
| 60D | 4Small Sample | 44.4% (4/9) | 50.0% (2/4) | -4.5% | -9.3% | -55.7% |
| 120D | 2Small Sample | 33.3% (2/6) | 0.0% (0/2) | -34.0% | -34.0% | -55.9% |
Research patterns
- First purchase in 12M
- 4/9
- Large purchase ≥ $100k
- 9/9
- Cluster buying · 15D
- 9/9
- Buying the dip
- 4/4
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.